Critically Important Cancer Outcomes to Report in Kidney Transplant Trials
| Published in: | Kidney International Reports |
|---|---|
| Main Authors: | Ellen Dobrijevic, Anita van Zwieten, Allison Jaure, Amy von Huben, Martin Howell, Armando Teixeira-Pinto, Sergio A. Acuna, Curie Ahn, Christopher D. Blosser, Jonathan C. Craig, Bianca Davidson, Anna Francis, Kenar D. Jhaveri, Jolanta Malyszko, Kenneth A. Newell, Alejandra Mena-Gutierrez, Naoka Murakami, Nicole Scholes-Robertson, Helio Tedesco Silva, Germaine Wong |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-10-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024925004371 |
Similar Items
Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review
by: Kenar D. Jhaveri, et al.
Published: (2017-01-01)
by: Kenar D. Jhaveri, et al.
Published: (2017-01-01)
Pitfalls of Current Diagnostic Criteria of Tumor Lysis Syndrome
by: Naji Alhamid, et al.
Published: (2024-03-01)
by: Naji Alhamid, et al.
Published: (2024-03-01)
Kidney and Urinary Tract Involvement in Chronic Myelomonocytic Leukemia
by: Rose Mary Attieh, et al.
Published: (2024-02-01)
by: Rose Mary Attieh, et al.
Published: (2024-02-01)
Navigating the Complexities of Cancer Treatment-Induced Hypertension
by: Jose Arriola-Montenegro, et al.
Published: (2025-06-01)
by: Jose Arriola-Montenegro, et al.
Published: (2025-06-01)
Establishing a core outcome measure for cancer in trials in kidney transplantation: a standardized outcomes in nephrology-kidney transplantation consensus workshop report
by: Ellen Dobrijevic, et al.
Published: (2026-06-01)
by: Ellen Dobrijevic, et al.
Published: (2026-06-01)
EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage
by: Abhishek Mishra, et al.
Published: (2025-09-01)
by: Abhishek Mishra, et al.
Published: (2025-09-01)
Chemotherapy-induced tubulopathy: a case report series
by: Mario Alamilla-Sanchez, et al.
Published: (2024-04-01)
by: Mario Alamilla-Sanchez, et al.
Published: (2024-04-01)
Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones
by: Maho Terashita, et al.
Published: (2023-12-01)
by: Maho Terashita, et al.
Published: (2023-12-01)
Renal involvement in solid cancers: epidemiological, clinical and histological characteristics study of 154 onconephrology patients
by: Victor Gueutin, et al.
Published: (2024-10-01)
by: Victor Gueutin, et al.
Published: (2024-10-01)
Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits
by: Antoine Morel, et al.
Published: (2021-04-01)
by: Antoine Morel, et al.
Published: (2021-04-01)
Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches
by: Rafaella Maria da Cunha Lyrio, et al.
Published: (2024-08-01)
by: Rafaella Maria da Cunha Lyrio, et al.
Published: (2024-08-01)
Editorial: Women in onconephrology: 2022
by: Ala Abudayyeh, et al.
Published: (2023-08-01)
by: Ala Abudayyeh, et al.
Published: (2023-08-01)
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario
by: Francesco Trevisani, et al.
Published: (2022-04-01)
by: Francesco Trevisani, et al.
Published: (2022-04-01)
Knowledge mapping and visualized analysis of research progress in onconephrology: a bibliometric analysis
by: Yiwei Wang, et al.
Published: (2025-12-01)
by: Yiwei Wang, et al.
Published: (2025-12-01)
WCN24-715 ADDRESSING SOCIAL DETERMINANTS OF HEALTH IN CHRONIC KIDNEY DISEASE: AN ANALYSIS OF HEALTH POLICY RESPONSES ACROSS AUSTRALIAN JURISDICTIONS
by: Javier Recabarren, et al.
Published: (2024-04-01)
by: Javier Recabarren, et al.
Published: (2024-04-01)
Consulta monográfica de onconefrología. Justificación y puesta en marcha
by: Fabiola Alonso, et al.
Published: (2021-03-01)
by: Fabiola Alonso, et al.
Published: (2021-03-01)
Acute Kidney Injury Secondary to Pegylated Liposomal Doxorubicin-Associated Renal-limited Thrombotic Microangiopathy
by: Tarek S. Karam, et al.
Published: (2025-05-01)
by: Tarek S. Karam, et al.
Published: (2025-05-01)
Acute Kidney Disease in Oncology: A New Concept to Enhance the Understanding of the Impact of Kidney Injury in Patients with Cancer
by: Matteo Floris, et al.
Published: (2024-08-01)
by: Matteo Floris, et al.
Published: (2024-08-01)
Rapidly Progressive Pauci-Immune Glomerulonephritis with Aberrant Fibrinoid Necrosis Associated with Atezolizumab, an Immune Check Point Inhibitor: A Case Report and Review of Literature
by: Petros Nikolopoulos, et al.
Published: (2023-01-01)
by: Petros Nikolopoulos, et al.
Published: (2023-01-01)
Cardiovascular and Renal Risk Stratification in Patients Referred to an Onconephrology Clinic and Undergoing Different Oncology Therapies: A Real-World Study
by: Silvia Lai, et al.
Published: (2026-06-01)
by: Silvia Lai, et al.
Published: (2026-06-01)
Editorial: Onconephrology: evolving concepts and challenges
by: Rogerio Passos, et al.
Published: (2025-04-01)
by: Rogerio Passos, et al.
Published: (2025-04-01)
The need for kidney biopsy in the management of side effects of target and immunotherapy
by: Roberta Fenoglio, et al.
Published: (2023-02-01)
by: Roberta Fenoglio, et al.
Published: (2023-02-01)
Human Adult Renal Progenitor Cells Prevent Cisplatin-Nephrotoxicity by Inducing CYP1B1 Overexpression and miR-27b-3p Down-Regulation through Extracellular Vesicles
by: Rossana Franzin, et al.
Published: (2023-06-01)
by: Rossana Franzin, et al.
Published: (2023-06-01)
Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates
by: Shun Kawashima, et al.
Published: (2022-06-01)
by: Shun Kawashima, et al.
Published: (2022-06-01)
WCN24-1842 NEPHROLOGISTS PERSPECTIVES AND ATTITUDES ON THE USE OF TELEHEALTH IN MANAGING PATIENTS WITH CHRONIC KIDNEY DISEASE
by: Brooke Huuskes, et al.
Published: (2024-04-01)
by: Brooke Huuskes, et al.
Published: (2024-04-01)
Anticancer drug-induced nephrotoxicity: biopsy-proven patterns and outcomes across chemotherapy, targeted therapy, and immune checkpoint inhibitors
by: Jing Tian, et al.
Published: (2025-12-01)
by: Jing Tian, et al.
Published: (2025-12-01)
A Global Survey of Self-Reported Cancer Screening Practices by Health Professionals for Kidney Transplant Candidates and Recipients
by: Nida Saleem, et al.
Published: (2025-01-01)
by: Nida Saleem, et al.
Published: (2025-01-01)
Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology
by: A. V. Smirnov, et al.
Published: (2020-07-01)
by: A. V. Smirnov, et al.
Published: (2020-07-01)
Monoclonal Gammopathy of Renal Significance: Consensus of Hematologists and Nephrologists of Russia on the Establishment of Nosology, Diagnostic Approach and Rationale for Clone Specific Treatment
by: A. V. Smirnov, et al.
Published: (2020-03-01)
by: A. V. Smirnov, et al.
Published: (2020-03-01)
A letter to the Master Clinician [v2; ref status: indexed, http://f1000r.es/2zh]
by: Kenar D. Jhaveri
Published: (2014-02-01)
by: Kenar D. Jhaveri
Published: (2014-02-01)
WCN25-644 SURVEY OF RENAL BIOPSY REGISTRY DATABASE AND ANTICANCER DRUG THERAPY IN JAPAN (SUBARU-J STUDY)
by: Takashige Kuwabara, et al.
Published: (2025-02-01)
by: Takashige Kuwabara, et al.
Published: (2025-02-01)
WCN24-1881 Interventions to improve life participation in kidney transplant recipients: a systematic review and meta-analysis
by: Anastasia Hughes, et al.
Published: (2024-04-01)
by: Anastasia Hughes, et al.
Published: (2024-04-01)
Does treating with anti–PD-1 to improve glomerular health come without a cost?
by: Kenar D. Jhaveri, et al.
Published: (2022-11-01)
by: Kenar D. Jhaveri, et al.
Published: (2022-11-01)
Home Dialysis in the Time of COVID-19: Reflections on Rapidly Changing Policies
by: Mala Sachdeva, et al.
Published: (2021-01-01)
by: Mala Sachdeva, et al.
Published: (2021-01-01)
“How Can I Uproot the System?”: Justice-Oriented Outcomes From Community-Based Research in Schools
by: Allison H. Blosser, et al.
Published: (2022-07-01)
by: Allison H. Blosser, et al.
Published: (2022-07-01)
Paraneoplastic Syndrome After Kidney Transplantation: Frequency, Risk Factors, Differences to Paraneoplastic Occurrence of Glomerulonephritis in the Native Kidney, and Implications on Long-Term Kidney Graft Function
by: Izabela Zakrocka, et al.
Published: (2024-07-01)
by: Izabela Zakrocka, et al.
Published: (2024-07-01)
Equity in national policies for Australians with kidney disease
by: Amanda Dominello, et al.
Published: (2021-08-01)
by: Amanda Dominello, et al.
Published: (2021-08-01)
Systematic Review of Patient and Caregiver Involvement in CKD Research
by: Talia Gutman, et al.
Published: (2025-06-01)
by: Talia Gutman, et al.
Published: (2025-06-01)
WCN24-1599 PATIENT-REPORTED OUTCOMES MEASURES FOR LIFE PARTICIPATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW
by: Anastasia Hughes, et al.
Published: (2024-04-01)
by: Anastasia Hughes, et al.
Published: (2024-04-01)
WCN24-1587 PATIENT-REPORTED OUTCOMES MEASURES FOR PATIENTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW
by: Anastasia Hughes, et al.
Published: (2024-04-01)
by: Anastasia Hughes, et al.
Published: (2024-04-01)
Similar Items
-
Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review
by: Kenar D. Jhaveri, et al.
Published: (2017-01-01) -
Pitfalls of Current Diagnostic Criteria of Tumor Lysis Syndrome
by: Naji Alhamid, et al.
Published: (2024-03-01) -
Kidney and Urinary Tract Involvement in Chronic Myelomonocytic Leukemia
by: Rose Mary Attieh, et al.
Published: (2024-02-01) -
Navigating the Complexities of Cancer Treatment-Induced Hypertension
by: Jose Arriola-Montenegro, et al.
Published: (2025-06-01) -
Establishing a core outcome measure for cancer in trials in kidney transplantation: a standardized outcomes in nephrology-kidney transplantation consensus workshop report
by: Ellen Dobrijevic, et al.
Published: (2026-06-01)
